Join us at #ACC21 to learn about #CMD

✅ What Is #CMD & Why Is It Important?
✅ Dx & Risk Stratification of #CMD: Stress Testing & Noninvasive Imaging
✅ Catheter-Based Techniques in Dx of #CMD
✅ Emerging Link Between #CMD & #HFpEF
✅ Phenotype-Based Mngmt of #CMD Image
#ACC21 #CMD session details 👇

📅 Sat, May 15
⏰ 2PM ImageImageImageImage
#ACC21 #ACCImaging #CMD session starting in 15 mins
Don’t miss this educational session Image
#ACC21 #ACCImaging #CMD
@AkoczoAgnes presenting an interesting case of #CMD to start our session ImageImageImageImage
#ACC21 #ACCImaging #CMD
@mdicarli is providing evidence & guidance for non-invasive imaging & functional testing for Dx of #CMD ImageImageImageImage
#ACC21 #ACCImaging #CMD
@JEscaned is providing rationale & guidance for invasive Dx of #CMD + emphasizing on importance of endotyping using invasive coronary physiology ImageImageImageImage
#ACC21 #ACCImaging #CMD
@HFpEF is providing evidence for an emergency link between #CMD & #HFpEF ImageImageImageImage
#ACC21 #ACCImaging #CMD
@MerzCn is providing guidance for Phenotype-Based Management of #CMD
Remember that endotyping & phenotyping is crucial for management of #CMD: One Size Does Not Fit All ImageImageImageImage

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Parham Eshtehardi MD

Parham Eshtehardi MD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @CoronaryDoc

16 May
9/19
#Tweetorial #CMD #ACC21

#CMD shares similar RFs w epicardial atherosclerosis (traditional ASCVD RFs) & is associated with several biomarkers of inflammation, oxidative stress & coagulation

🔗futuremedicine.com/doi/10.2217/fc…
🔗sciencedirect.com/science/articl…
🔗atherosclerosis-journal.com/article/S0021-… Image
10/19
#Tweetorial #CMD #ACC21

There is significant overlap between #CMD & epicardial disease

Large number of patients w/ #CMD also have epicardial atherosclerosis (obstructive or non-obstructive) & epicardial endothelial dysfunction

🔗onlinelibrary.wiley.com/doi/abs/10.100… ImageImage
11/19
#Tweetorial #CMD #ACC21

In our IVUS study:
✅ Most patients with #CMD had significant plaque burden
✅ Patients with #CMD had higher plaque burden & more diffuse atherosclerosis as compared to patients w/o CMD

🔗jacc.org/doi/full/10.10… Image
Read 11 tweets
16 May
#CMD #Tweetorial

⚡ Coronary Microvascular Dysfunction ⚡

1/19

📌 What Is #CMD
📌 Why Is #CMD Important❓

Based on my #ACC21 #ACCImaging presentation Image
2/19
#Tweetorial #CMD #ACC21

Let’s start by talking about angina

✅ Angina w/o obstructive CAD is very prevalent 

🔗ahajournals.org/doi/full/10.11… Image
3/19
#Tweetorial #CMD #ACC21

✅ Angina ➡ poor prognosis
✅ Angina with no obstructive CAD = ⬆ risks of CV events compared to no angina, even after adjusting for traditional RFs & co-morbidities

🔗academic.oup.com/eurheartj/arti… Image
Read 9 tweets
26 Sep 20
#Tweetorial on #ASNC2020 session

⚡Selecting Between Different Functional Tests⚡

☢ vs 🧲 vs ⏺ ❓

🔘 Strengths/Limits of Lesion Specific vs Myocardial Ischemia
🔘 Comparing Dx Accuracy of Tests
🔘 Ischemia Testing in #INOCA
🔘 How to Select Best Noninvasive Test

1/9
#ASNC2020 #cvNuc
2/9
Dr Di Carli

☢ Issues with proposed #FFR threshold 0.8
☢ Exercise MPI correlates well with FFR but not at 0.8
☢ Benefit of FFR-guided revasc dominantly occurs w/ thresholds <0.8
☢ Quantification of lesion-specific #ischemia insufficient for patient mgmt
#ASNC2020 #cvNuc
3/9
Dr Di Carli

Lesion-specific #ischemia measurements (FFR/#FFRCT)

☢ Strength
Validated against ETT/MPI
Strong outcome data
Guidelines supported

☢ Limit
Controversial threshold (0.80 vs MPI-validated 0.66)
⬆ microvasc resist causes FFR pseudonormalization
Read 11 tweets
8 Sep 20
☢ Selecting Between Different Functional Tests in 2020? ☢

This should be most interesting session of virtual #ASNC2020

I am excited to be virtual moderator w/ expert speakers Dan Berman, Keon Nieman, Paul Knaapen, @mdicarli, @VTaqMD

#cvImaging #cvNuc #CardioTwitter ImageImageImage
Are you ready for most exciting #ASNC2020 session?

⚡Selecting Between Different Functional Tests⚡

☢ vs 🧲 vs ⏺ ❓

Let’s hear from #cvImaging giants
Keon Nieman, Paul Knaapen, @mdicarli @VTaqMD @danielbermanmd

📆 Sat, Sept 26
⏰ 2:15 to 3:30PM
🗒 bit.ly/333dRNO ImageImageImageImage
☢ This super exciting session starts in 3 hours ☢

📺 Tune in #cvNuc peeps to learn who benefits from ischemia testing & how to select best non-invasive test

⏰ 2:15 to 3:30PM
#ASNC2020 Image
Read 9 tweets
31 Aug 20
Did you know?

#ASNC2020 @MyASNC Virtual is scheduled over several wks

☢ Bulk of sessions ➡ Friday & Saturday, Sept 25 & 26

☢ Cases with Aces sessions ➡ once a wk, Sept 9 to Oct 7

☢ 2 #SoMe sessions ➡ Sept 10 & 17 at 4:00pm

☢ Technologist sessions ➡ Oct 3 Image
Join us on Sept 10 & 17 for #ASNC2020 virtual #SoMe sessions

1⃣ #SoMe Session Sep 10 @ 4:00pm EDT
☢ Leveraging #SoMe for Patient Care
bit.ly/3hPrbKC

2⃣ #SoMe Session Sep 17 @ 4:00pm EDT
☢ Steering Your Tweetanic
bit.ly/2GqaDes Image
Read 4 tweets
26 Jul 20
Great talk on #CardioObstetrics
by @RBP0612 at #ASPC20
1/3 ImageImageImageImage
Great talk on #CardioObstetrics
by @RBP0612 at #ASPC20
2/3 ImageImageImageImage
Great talk on #CardioObstetrics
by @RBP0612 at #ASPC20
3a/3 ImageImageImageImage
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(